Cost analysis of antibiotics in the management of perforated or gangrenous appendicitis
- 1 February 1986
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Surgery
- Vol. 151 (2), 200-204
- https://doi.org/10.1016/0002-9610(86)90069-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Cost Containment of Reconstituted Parenteral Antibiotics: Personnel and Supply Costs Associated with Preparation, Dispensing, and AdministrationClinical Infectious Diseases, 1984
- Economic Analysis of a New Drug: Potential Savings in Hospital Operating Costs from the Use of a Once-Daily Regimen of a Parenteral CephalosporinClinical Infectious Diseases, 1984
- New Drugs and Clinical Economics: Analysis of Cost Effectiveness in the Assessment of Pharmaceutical InnovationsClinical Infectious Diseases, 1984
- Risk Factors for Nephrotoxicity in Patients Treated with AminoglycosidesAnnals of Internal Medicine, 1984
- Perforated and Gangrenous Appendicitis: An Analysis of Antibiotic FailuresThe Journal of Infectious Diseases, 1983
- The Influence of Dose Frequency and Agent Toxicity on the Cost of Parenteral Antibiotic TherapyDrug Intelligence & Clinical Pharmacy, 1982
- Antibiotic management of surgically treated gangrenous or perforated appendicitis: Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazoneThe American Journal of Surgery, 1982
- Prophylactic and Preventive Antibiotic Therapy Timing, Duration and EconomicsAnnals of Surgery, 1979